Clinical Trial Update: A Parallel-group Active Comparator, Double-blind, Multicenter, Randomized, Double-blind, Phase III Clinical Study [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial for knee osteoarthritis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Knee Osteoarthritis | Phase 3 | Status: WITHDRAWN